Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • FROM THE ANALYST'S COUCH

AI in small-molecule drug discovery: a coming wave?

  1. Madura K.P. Jayatunga

    1. Boston Consulting Group, London, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  2. Wen Xie

    1. Boston Consulting Group, Beijing, China.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  3. Ludwig Ruder

    1. Boston Consulting Group, Zurich, Switzerland.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  4. Ulrik Schulze

    1. Boston Consulting Group, Zurich, Switzerland.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  5. Christoph Meier

    1. Boston Consulting Group, London, UK.

    View author publications

    You can also search for this author in PubMed  Google Scholar

Artificial intelligence (AI) offers the potential to transform drug discovery. Over the last few years, AI-enabled drug discovery has grown substantially through technological progress, such as the use of neural networks to design molecules and the application of knowledge graphs to understand target biology.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature Reviews Drug Discovery 21, 175-176 (2022)

doi: https://doi.org/10.1038/d41573-022-00025-1

Supplementary Information

  1. Supplementary information

Competing Interests

The authors of this article are employees of The Boston Consulting Group (BCG), a management consultancy that works with the world's leading biopharmaceutical companies. The research for this specific article was funded by BCG's Health Care practice.

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links